« Back
Home /
ELF4 Antibody (Center) Blocking Peptide

ELF4 Antibody (Center) Blocking Peptide

Item no.	ABC-BP7185c
Manufacturer	Abcepta
Amount	500 ug
Category	Peptides & Proteins Peptides
Type	Peptides
Format	Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Specific against	other
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Similar products	ETS-related transcription factor Elf-4, E74-like factor 4, Myeloid Elf-1-like factor, ELF4 {ECO:0000312\|EMBL:CAI428821}
Available
Primary Accession	Q99607
Bio Background	ELF4 is transcriptional activator that binds to DNA sequences containing the consensus 5'-WGGA-3'. The protein acts synergistically with RUNX1 to transactivate the IL3 promoter. Also transactivates the PRF1 promoter in natural killer (NK) cells. This protein plays a role in the development and function of NK and NK T-cells and in innate immunity.
Bio References	Miyazaki Y., Sun X.Oncogene 13:1721-1729(1996) Aryee D.N.T., Petermann R.Gene 210:71-78(1998)Mao S., Frank R.C., Zhang J.Mol. Cell. Biol. 19:3635-3644(1999)
Gene ID	2000
Gene Name	ELF4 {ECO:0000312\|EMBL:CAI42882.1}
Subtitle	Synthetic peptide
Target/Specificity	The synthetic peptide sequence used to generate the antibody AP7185c was selected from the Center region of human ELF4. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

ABC-BP7185c-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 500 ug

available

Delivery expected until 10/4/2024